Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

James S. Lewis, PharmD, FIDSA

Infectious Disease Pharmacist
Oregon Health and Science University

Disclosure(s): Cidara: Advisor/Consultant; Merck: Advisor/Consultant; SeLux Diagnostics: Advisor/Consultant

Poster(s):

975 - Dalbavancin for the Treatment of Vertebral Osteomyelitis
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET
1004 - Dalbavancin Use and Associated Cost-Savings: An Update
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET
215b - Real-World Experience of Letermovir Use at an Academic Transplant Center
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET